OTCMKTS:CNVVY - ConvaTec Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
+0.30 (1.20%)

This chart shows the closing price for CNVVY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ConvaTec Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNVVY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNVVY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for ConvaTec Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $14.67.

This chart shows the closing price for CNVVY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 contributing investment analysts is to hold stock in ConvaTec Group. This rating has held steady since December 2019, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/1/2021Royal Bank of CanadaReiterated RatingSector Perform
5/10/2021BarclaysReiterated RatingOverweight
5/6/2021Peel HuntUpgradeBuy
5/4/2021Credit Suisse GroupReiterated RatingUnderperform
4/30/2021BarclaysReiterated RatingOverweight
4/30/2021JPMorgan Chase & Co.Reiterated RatingNeutral
3/8/2021JPMorgan Chase & Co.Reiterated RatingNeutral
1/19/2021BarclaysReiterated RatingOverweight
1/4/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
12/9/2020Morgan StanleyReiterated RatingEqual Weight
11/18/2020Morgan StanleyReiterated RatingEqual Weight
10/29/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
10/29/2020BarclaysReiterated RatingOverweight
9/29/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
9/23/2020BarclaysUpgradeEqual Weight ➝ Overweight
9/23/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
8/7/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
8/7/2020Credit Suisse GroupReiterated RatingUnderperform
7/2/2020Morgan StanleyReiterated RatingEqual Weight
7/1/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
6/26/2020Peel HuntDowngradeBuy
5/18/2020BarclaysReiterated RatingEqual Weight
4/1/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
1/20/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
12/9/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
11/12/2019Sanford C. BernsteinInitiated CoverageUnderperform
10/26/2018UBS GroupDowngradeBuy ➝ Neutral
10/16/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
10/16/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral
10/3/2018Jefferies Financial GroupInitiated CoverageBuy
(Data available from 7/25/2016 forward)
ConvaTec Group logo
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urological catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
Read More

Today's Range

Now: $14.67
Low: $14.67
High: $14.67

50 Day Range

MA: $13.63
Low: $12.60
High: $14.67

52 Week Range

Now: $14.67
Low: $9.00
High: $14.67


50 shs

Average Volume

1,194 shs

Market Capitalization


P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of ConvaTec Group?

The following equities research analysts have issued reports on ConvaTec Group in the last twelve months: Barclays PLC, Credit Suisse Group AG, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Peel Hunt, and Royal Bank of Canada.
View the latest analyst ratings for CNVVY.

What is the current price target for ConvaTec Group?

0 Wall Street analysts have set twelve-month price targets for ConvaTec Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ConvaTec Group in the next year.
View the latest price targets for CNVVY.

What is the current consensus analyst rating for ConvaTec Group?

ConvaTec Group currently has 1 sell rating, 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CNVVY, but not buy more shares or sell existing shares.
View the latest ratings for CNVVY.

What other companies compete with ConvaTec Group?

How do I contact ConvaTec Group's investor relations team?

The company's listed phone number is 441189528100. The official website for ConvaTec Group is www.convatecgroup.com.